ArticleStrategies in trauma and limb reconstruction
Early Experience of Femoral Lengthening with the FITBONE Nail in Adolescents.
Article in Strategies in trauma and limb reconstruction. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim and background: Intramedullary limb lengthening nails are increasingly used in patients nearing skeletal maturity. Following the temporary withdrawal of magnetically driven systems, the electrically powered FITBONE nail has been used at our institution since March 2021. This study aims to present the early experience of this nail with particular attention to complications, regenerative healing, and the learning curve. Materials and methods: A single-center retrospective study was performed, including adolescent patients who underwent femoral lengthening with antegrade or retrograde FITBONE nails and progressed to full weight-bearing (FWB). Outcome measures included length gained, distraction index (DI), weight-bearing index (WBI), mechanical axis parameters, complications, and patient-reported outcomes using the Paediatric Quality of Life (PedsQL) Questionnaire. Results: A total of 15 (eight males, seven females) patients with a mean age of 16.9 years, with varied diagnoses of leg length discrepancy (LLD), were analysed. Mean length gained was 39 mm with a mean DI of 0.75 mm/day. Weight-bearing index in these patients, on average, was 57.4 days/cm lengthened. Four complications were observed, including two nonunions (both successfully treated) and two knee subluxations. Mechanical axis deviation improved from 12.1 to 7 mm on average. A significant reduction in WBI was observed with increasing surgical experience (Spearman's ρ = -0.58, Conclusion: Femoral lengthening using the FITBONE nail in adolescents approaching skeletal maturity is an effective and relatively safe procedure, with complication rates and outcomes comparable to other intramedullary lengthening systems. A learning curve was evident, reflected by earlier progression to FWB without an increase in complications. Clinical significance: Surgeons experienced with intramedullary limb lengthening can expect outcomes and complication profiles comparable to other motorised nail systems when using FITBONE. However, the relatively large barrel diameter (12 mm) may limit its use in patients with narrow femoral canals and should be considered during patient selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.